ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,913, issued on Aug. 25, was assigned to SHANGHAI MABGEEK BIOTECH. Co. LTD. (Shanghai).

"Antibody against human thymic stromal lymphopoietin, method and application" was invented by Jinlin Guo (Shanghai), Yujing Yuan (Shanghai), Wei Dang (Shanghai), Yipan Wu (Shanghai), Lingqiao Zhu (Shanghai), Chenghai Zhang (Shanghai), Qiuling Zou (Shanghai), Zhike Li (Shanghai) and Yang Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are an antibody capable of binding to human thymic stromal lymphopoietin (hTSLP), a preparation method therefor and an application thereof. The anti-hTSLP antibody of the present invent...